Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 483 of 5804
-
Tiny radioactive spheres aim to destroy kidney tumors without surgery
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects and effectiveness of radioembolization with yttrium-90 (Y-90) in patients with early stage renal cell carcinoma. Y-90 is a radioactive chemical that is incorporated into millions of very tiny glass spheres. These spheres are in…
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for chemo-resistant breast cancer: targeted radiation before surgery
Disease control Recruiting nowThe goal of this clinical trial is to assess whether the addition of preoperative stereotactic body radiation therapy (SBRT) can improve pathological complete response (pCR) rates and safety in breast cancer patients who do not respond to initial neoadjuvant chemotherapy. The mai…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New balloon treatment could rival standard stent for heart attacks
Disease control Recruiting nowThe objective of the study is to compare drug-coated balloon (DCB) with the gold standard drug-eluting stent (DES) in percutaneous coronary intervention (PCI) for patients presenting with ST-elevation myocardial infarction (STEMI). Randomization will be performed after successfu…
Phase: NA • Sponsor: Institute of Cardiovascular Diseases, Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis single-arm, open-label, multicenter, Phase I study will evaluate the safety, tolerability, anti-tumor activity, pharmacokinetics (PK)/pharmacodynamics (PD), biomarker, and immunogenicity of C-CAR031 in adult participants with GPC3+ advanced/metastatic squamous cell lung canc…
Phase: PHASE1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare blood cancers: targeted drug trial opens
Disease control Recruiting nowIndolent T/NK-cell lymphomas are a heterogeneous group of lymphoproliferative diseases originating from T/NK cells, characterized by slow growth and proliferation, but currently remain incurable. For indolent T/NK-cell lymphomas that are unresponsive to first-line treatment, ther…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New trial tests quick valve fix after heart attack to save lives
Disease control Recruiting nowTo explore the impact of early transcatheter edge-to-edge repair of acute functional mitral regurgitation after myocardial infarction on the combined incidence of death and heart-failure associated hospitalisations at one-year follow-up, and quality of life and LV remodelling at …
Phase: NA • Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Recruiting nowA Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Moderate to Severe Active Systemic Lupus Erythematosus
Phase: EARLY_PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Weight-Loss pill VCT220 enters final testing phase
Disease control OngoingThe main purpose of this study is to assess how VCT220 tablets affect the bodyweight in obese or overweight adult participants. Participant will be randomly assigned to the high-dose group, low-dose group, or placebo group. Each participant will take the study drug orally once da…
Phase: PHASE3 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
App could make methadone treatment easier and cheaper
Disease control Recruiting nowMethadone is an effective treatment for severe opioid use disorder (OUD), but access is limited due to the requirement of daily observed dosing by most opioid treatment programs (OTPs). Sonara Health designed a HIPAA-compliant web-application called Sonara that features integrate…
Phase: PHASE2 • Sponsor: Sonara Health • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Immunotherapy plus chemo shows promise for rare sinus cancer
Disease control Recruiting nowThis study will test the Safety and activity of pembrolizumab plus chemotherapy as neoadjuvant treatment in locally advanced sinonasal undifferentiated carcinoma (SNUC). Activity of neoadjuvant chemotherapy in locally advanced SNUC has been already demonstrated; the primary hypo…
Phase: PHASE2 • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for GVHD patients: ruxolitinib tested as First-Line therapy
Disease control Recruiting nowAllogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has failed 1-2 prior lines of therapy based on a prior large, randomized phase III s…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New PET scan targets hidden cancers with precision
Diagnosis Recruiting nowThis study aims to determine the value of cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging for diagnosing human malignancies, including renal cell carcinoma (particularly clear cell renal cell carcinoma), ly…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New ASL-Based therapy aims to tackle alcohol and trauma in deaf community
Disease control Recruiting nowThe U.S. Deaf community - a group of more than one million Americans who communicate using American Sign Language (ASL) - experiences nearly triple the rate of lifetime problem drinking and twice the rate of trauma exposure compared to the general population. Although there are s…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heating up tumors: could thermal therapy boost immune attack on breast cancer?
Disease control CompletedIn this study, breast cancer (BC) patients eligible for inclusion will be divided into two groups according to molecular typing and subtyping, which combined immunotherapy and multimodal thermal therapy with conventional neoadjuvant chemotherapy, to explore methods of immune indu…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New sleepiness drug could change lives for narcolepsy and hypersomnia patients
Symptom relief Recruiting nowNarcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with these conditions might find it hard to stay alert…
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Brain bleed breakthrough? embolization procedure aims to stop repeat hematomas
Disease control Recruiting nowCOMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle m…
Phase: NA • Sponsor: Kazutaka Uchida • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New imaging agent could spot multiple cancers with one scan
Diagnosis Recruiting nowThis study aims to establish and optimize the trophoblast cell surface antigen 2 (Trop2)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging method and its physiological and pathological distribution characteristics, based on which the diagnost…
Phase: PHASE2, PHASE3 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Hope for cancer patients: drug may shield ears from chemo damage
Prevention Recruiting nowThe purpose of this study is to evaluate the efficacy of N-acetylcysteine (NAC) in preventing cisplatin-induced ototoxicity in patients receiving cisplatin-based chemotherapy. Cisplatin is a highly effective chemotherapeutic agent but often leads to permanent hearing loss (ototox…
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New triple therapy shows promise for tough lung cancer
Disease control Recruiting nowMulticenter, Phase II Randomized Controlled Study of Adebrelimab Combined with Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a daily pill tame severe eczema in kids?
Disease control OngoingPediatric atopic dermatitis (AD), also known as childhood eczema, is a skin condition that may cause a rash and itching due to inflammation of the skin. The purpose of this study is to assess the change in disease activity (Efficacy) and to assess the safety of upadacitinib in co…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC